These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Review of single- and multiple-dose pharmacokinetics of the monobactam, aztreonam (SQ 26,776) in healthy subjects. Swabb EA; Sugerman AA Chemotherapy; 1983; 29(5):313-21. PubMed ID: 6684541 [TBL] [Abstract][Full Text] [Related]
4. The effect of probenecid on the renal elimination of cimetidine. Gisclon LG; Boyd RA; Williams RL; Giacomini KM Clin Pharmacol Ther; 1989 Apr; 45(4):444-52. PubMed ID: 2702802 [TBL] [Abstract][Full Text] [Related]
5. Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects. Swabb EA; Sugerman AA; Platt TB; Pilkiewicz FG; Frantz M Antimicrob Agents Chemother; 1982 Jun; 21(6):944-9. PubMed ID: 7202343 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of renal tubular transport of methotrexate by probenecid. Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785 [TBL] [Abstract][Full Text] [Related]
8. Renal tubular secretion and effects of furosemide. Odlind B; Beermann B Clin Pharmacol Ther; 1980 Jun; 27(6):784-90. PubMed ID: 7379446 [TBL] [Abstract][Full Text] [Related]
9. Coupling between renal tubular secretion and effect of bumetanide. Odlind B; Beermann B; Lindström B Clin Pharmacol Ther; 1983 Dec; 34(6):805-9. PubMed ID: 6641097 [TBL] [Abstract][Full Text] [Related]
10. The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion. Verhagen CA; Mattie H; Van Strijen E Br J Clin Pharmacol; 1994 Feb; 37(2):193-7. PubMed ID: 8186065 [TBL] [Abstract][Full Text] [Related]
11. Tubular mechanisms determining the urinary excretion of tritiated prostaglandin E2 in the anaesthetized rat. Haylor J; Lote CJ; Towers JD J Physiol; 1988 Sep; 403():1-14. PubMed ID: 3253420 [TBL] [Abstract][Full Text] [Related]
12. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination. Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol. Gross AS; McLachlan AJ; Minns I; Beal JB; Tett SE Br J Clin Pharmacol; 2001 Jun; 51(6):547-55. PubMed ID: 11422014 [TBL] [Abstract][Full Text] [Related]
15. No effect of probenecid on the renal and biliary clearances of digoxin in man. Hedman A; Angelin B; Arvidsson A; Dahlqvist R Br J Clin Pharmacol; 1991 Jul; 32(1):63-7. PubMed ID: 1888643 [TBL] [Abstract][Full Text] [Related]
16. Renal handling of fleroxacin in rabbits, dogs, and humans. Shiba K; Saito A; Shimada J; Hori S; Kaji M; Miyahara T; Kusajima H; Kaneko S; Saito S; Ooie T Antimicrob Agents Chemother; 1990 Jan; 34(1):58-64. PubMed ID: 2109576 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of "true" creatinine clearance in rats reveals extensive renal secretion. Darling IM; Morris ME Pharm Res; 1991 Oct; 8(10):1318-22. PubMed ID: 1796052 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion. Burgess DS; Summers KK; Hardin TC Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260 [TBL] [Abstract][Full Text] [Related]
19. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid. Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180 [TBL] [Abstract][Full Text] [Related]